← FDA Drug Approvals (Drugs@FDA)

FLOLIPID

NDA · New Drug Application · Sponsor: SALERNO PHARMS · Approved 2016-04-21

Drug application

FDA Application #

NDA206679

Application type

New Drug Application

Brand name

FLOLIPID

Generic name

Simvastatin

Active ingredients

SIMVASTATIN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

SALERNO PHARMS

First approval

2016-04-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown